Market Cap 4.02B
Revenue (ttm) 441.54M
Net Income (ttm) 35.46M
EPS (ttm) N/A
PE Ratio 68.53
Forward PE 59.68
Profit Margin 8.03%
Debt to Equity Ratio 0.26
Volume 1,684,200
Avg Vol 1,159,616
Day's Range N/A - N/A
Shares Out 33.82M
Stochastic %K 71%
Beta 1.91
Analysts Strong Sell
Price Target $110.00

Latest News on TMDX

TransMedics: Exceptional Q1 Undermines The Short Narrative

May 9, 2025, 9:48 AM EDT - 4 days ago

TransMedics: Exceptional Q1 Undermines The Short Narrative


TransMedics Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 5 days ago

TransMedics Reports First Quarter 2025 Financial Results


TransMedics: Get Some Exposure Despite Market Concerns

Apr 23, 2025, 4:23 AM EDT - 21 days ago

TransMedics: Get Some Exposure Despite Market Concerns